EN1 中文

Pharmaceutical Research

Pharmaceutical Research
Medicinal Chemistry
Process R&D
Pharmaceutical Research
Molecular Building Blocks
Pharmacokinetics

Impurity studies

  • Impurity profile studies: Organic impurities, Inorganic impurities, Elemental impurities, Residual solvents, Degradation impurities, Potential genotoxic impurities.
  • Impurity synthesis, Structure identification and Impurity calibration: Synthesis and structure characterization by Single crystal X-ray diffraction(s-XRD), Microcrystalline electron diffraction (MicroED) ect.
  • Impurity limit studies: Determination for impurity limits of each intermediate through impurity source analysis/clearing/spiking and degradation studies; determination of API’s impurities and impurity content based on safety risk assessment
  • Genotoxic impurity studies: Genotoxicity prediction of impurities based on (Q)SAR (Derek&Sarah or Toxtree software);
    Genotoxicity risk assessment using bacterial reverse mutation experiments (Ames tests) for high-risk impurities;
    Limits calculation for genotoxic impurities based on ICH M7 guidelines
  • Address

    Bldg. 12, No. 59 Kai Qing Rd, Pudong, Shanghai (West Campus)

    Bldg. 7, No. 509 Ren Qing Rd, Pudong, Shanghai (East Campus)

  • Investment Contact

    +86-21-50720228-202

  • Email

    sales@pharmaresources.cn

    Will reply as soon as possible.

Copyright © Copyright 2024 PharmaResources (Shanghai) Co., Ltd. (Official Website)---Privacy Policy

Reference No： Shanghai ICP 20013779 Website Constructed by：Ocean Design, Shanghai